|
1
|
Sairazi NS and Sirajudeen KNS: Natural products and their bioactive compounds: Neuroprotective potentials against neurodegenerative diseases. Evid Based Complement Alternat Med. 2020(6565396)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu Z, Zhou T, Ziegler AC, Dimitrion P and Zuo L: Oxidative stress in neurodegenerative Diseases: From molecular mechanisms to clinical applications. Oxid Med Cell Longev. 2017(2525967)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sharifi-Rad M, Lankatillake C, Dias DA, Docea AO, Mahomoodally MF, Lobine D, Chazot PL, Kurt B, Tumer TB, Moreira AC, et al: Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics. J Clin Med. 9(1061)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Naomi R, Yazid MD, Teoh SH, Balan SS, Shariff H, Kumar J, Bahari H and Embong H: Dietary polyphenols as a protection against cognitive decline: Evidence from animal experiments; mechanisms and limitations. Antioxidants (Basel). 12(1054)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ramis MR, Sarubbo F, Moranta D, Tejada S, Lladó J, Miralles A and Esteban S: Cognitive and neurochemical changes following polyphenol-Enriched diet in rats. Nutrients. 13(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Grosso C, Santos M and Barroso MF: From plants to Psycho-neurology: Unravelling the therapeutic benefits of bioactive compounds in brain disorders. Antioxidants (Basel). 12(1603)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bonacaro A, Arosio M, Svelto A and Tettamanti M: The effects of essential oil and massage on patients affected by Alzheimer's disease. J Gerontological Nurs. 48:39–47. 2022.
|
|
8
|
Xu H and Yang F: The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl Psychiatry. 12(464)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Daubner SC, Le T and Wang S: Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys. 508:1–12. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cruickshank L, Kennedy AR and Shankland N: ‘CSD Entry TIRZAX: 5-(2 Ammonioethyl)-2-hydroxyphenolate, Dopamine’. Cambridge Structural Database: Access Structures. Cambridge Crystallographic Data Centre, 2013 doi:10.5517/cc10m9nl.
|
|
11
|
Best JA, Nijhout HF and Reed MC: Homeostatic mechanisms in dopamine synthesis and release: A mathematical model. Theor Biol Med Model. 6(21)2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Berry MD, Juorio AV and Li XM: Aromatic L-amino acid decarboxylase: A neglected and misunderstood enzyme. Neurochem Res. 21:1075–1087. 1996.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cho HU, Kim S and Sim J: Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis. Exp Mol Med. 53:1148–1158. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR and Kleinman JE: Catechol-O-methyl transferase genotype and dopamine regulation in the human brain. J Neurosci. 23:2008–2013. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Franco R, Reyes-Resina I and Navarro G: Dopamine in health and disease: Much more than a neurotransmitter. Biomedicines. 9(109)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Joshi R, Kulkarni YA and Wairkar S: Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life Sci. 215:43–56. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kumar S and Pandey AK: Chemistry and biological activities of flavonoids: An overview. ScientificWorldJournal. 2013(162750)2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gattuso G, Barreca D, Gargiulli C, Leuzzi U and Caristi C: Flavonoid composition of citrus juices. Molecules. 12:1641–1673. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shilpa VS, Shams R, Dash KK, Pandey VK, Dar AH, Ayaz Mukarram S, Harsányi E and Kovács B: Phytochemical properties, extraction, and pharmacological benefits of naringin: A review. Molecules. 28(5623)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Emran TB, Islam F, Nath N, Sutradhar H, Das R, Mitra S, Alshahrani MM, Alhasaniah AH and Sharma R: Naringin and naringenin polyphenols in neurological diseases: Understandings from a therapeutic viewpoint. Life (Basel). 13(99)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen C, Wei YZ, He XM, Li DD, Wang GQ, Li JJ and Zhang F: Naringenin produces neuroprotection against LPS-Induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation. Front Immunol. 10(936)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yilmaz E, Acar G, Onal U, Erdogan E, Baltaci AK and Mogulkoc R: Effect of 2-Week naringin supplementation on neurogenesis and BDNF levels in ischemia-reperfusion model of rats. Neuromolecular Med. 26(4)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen J, Sun J, Jiang J and Zhou J: Cyanidin protects SH-SY5Y human neuroblastoma cells from 1-Methyl-4-Phenylpyridinium-induced neurotoxicity. Pharmacology. 102:126–132. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Araújo FF, de Paulo Farias D, Neri-Numa IA and Pastore GM: Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 338(127535)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cao G, Muccitelli HU, Sánchez-Moreno C and Prior RL: Anthocyanins are absorbed in glycated forms in elderly women: A pharmacokinetic study. Am J Clin Nutr. 73:920–906. 2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rahman S, Mathew S, Nair P, Ramadan WS and Vazhappilly CG: Health benefits of cyanidin-3-glucoside as a potent modulator of Nrf2-mediated oxidative stress. Inflammopharmacology. 29:907–923. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Thummayot S, Tocharus C, Jumnongprakhon P, Suksamrarn A and Tocharus J: Cyanidin attenuates Aβ25-35-induced neuroinflammation by suppressing NF-κB activity downstream of TLR4/NOX4 in human neuroblastoma cells. Acta Pharmacol Sin. 39:1439–1452. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Enogieru AB, Haylett W, Hiss DC, Bardien S and Ekpo OE: Rutin as a potent antioxidant: Implications for neurodegenerative disorders. Oxid Med Cell Longev. 2018(6241017)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chaudhuri A: Multiple sclerosis is primarily a neurodegenerative disease. J Neural Transm (Vienna). 120:1463–1466. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Khan MM, Raza SS, Javed H, Ahmad A, Khan A and Islam F, Safhi MM and Islam F: Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Neurotox Res. 22:1–5. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Budzynska B, Faggio C, Kruk-Slomka M, Samec D, Nabavi SF, Sureda A, Devi KP and Nabavi SM: Rutin as neuroprotective agent: From bench to bedside. Curr Med Chem. 26:5152–5164. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Phan CW, David P, Wong KH, Naidu M and Sabaratnam V: Uridine from pleurotus giganteus and its neurite outgrowth stimulatory effects with underlying mechanism. PLoS One. 10(e0143004)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Phan CW, Wong WL, David P, Naidu M and Sabaratnam V: Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde: Nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells. BMC Complement Altern Med. 12(102)2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wurtman RJ: A nutrient combination that can affect synapse formation. Nutrients. 6:1701–1710. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Carver JD: Advances in nutritional modifications of infant formulas. Am J Clin Nutr. 77 (Suppl):1550S–1554S. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gasser T, Moyer JD and Handschumacher RE: Novel Single-pass exchange of circulating uridine in rat liver. Science. 213:777–778. 1981.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Fukuchi M and Hada T: Effect of beer on the plasma concentrations of uridine and purine bases. Metabolism. 51:1317–1323. 2002.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yamamoto T, Moriwaki Y, Takahashi S, Yamakita J, Tsutsumi Z, Ohata H, Hiroishi K, Nakano T and Higashino K: Effect of ethanol and fructose on plasma uridine and purine bases. Metabolism. 46:544–547. 1997.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hidalgo A, Pompei C, Galli A and Cazzola S: Uracil as an index of lactic acid bacteria contamination of tomato products. J Agric Food Chem. 53:349–355. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhang Y, Guo S, Xie C and Fang J: Uridine metabolism and its role in glucose, lipid, and amino acid homeostasis. Biomed Res Int. 2020(7091718)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Stryer B and T: Glycolysis Is an Energy-Conversion Pathway in Many Organisms. In: Stryer B, Tymoczko JL, (eds.) Glycolysis Is an Energy-Conversion Pathway in Many Organisms. 5th edition, New York, W H Freeman, 2002.
|
|
42
|
Agarwal N, Sung YH, Jensen JE, daCunha G, Harper D, Olson D and Renshaw PF: Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: A 31-phosphorus magnetic resonance spectroscopy study at 4T. Bipolar Discord. 12:825–833. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yamamoto T, Koyama H, Kurajoh M, Shoji T, Tsutsumi Z and Moriwaki Y: Biochemistry of uridine in plasma. Clin Chim Acta. 412:1712–1724. 2011.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Cansev M: Uridine and cytidine in the brain: Their transport and utilization. Brain Res Rev. 52:389–397. 2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Dobolyi A, Juhasz G, Kovacs Z and Kardos J: Uridine function in the central nervous system. Curr Top Med Chem. 11:1058–1067. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bikle DD: Feingold KR ABBM. Vitamin D: Production, Metabolism and Mechanisms of Action. In: Vitamin D: Production, Metabolism and Mechanisms of Action. South Dartmouth (MA), 2021.
|
|
47
|
Trinko JR, Land BB, Solecki WB, Wickham RJ, Tellez LA, Maldonado-Aviles J, de Araujo IE, A Addy N and DiLeone RJ: Vitamin D3: A role in dopamine circuit regulation, diet-induced obesity, and drug consumption. eNeuro 3: ENEURO.0122-15.2016, 2016.
|
|
48
|
Kesby JP, Cui X, Ko P, McGrath JJ, Burne THJ and Eyles DW: Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci Lett. 461:155–158. 2009.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Aubert PM, Seibyl JP, Price JL, Harris TS, Filbey FM, Jacobe H, Devous MD Sr and Adinoff B: Dopamine efflux in response to ultraviolet radiation in addicted sunbed users. Psychiatry Res Neuroimaging. 251:7–14. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tsai HY, Chen KC, Yang YK, Chen PS, Yeh TL, Chiu NT and Lee IH: Sunshine-exposure variation of human striatal dopamine D2/D3 receptor availability in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 35:107–110. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Grippo RM, Purohit AM, Zhang Q, Zweifel LS and Güler AD: Direct midbrain dopamine input to the suprachiasmatic nucleus accelerates circadian entrainment. Curr Biol. 27:2465–2475.e3. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Taylor CL, Patterson KY, Roseland JM, Wise SA, Merkel JM, Pehrsson PR and Yetley EA: Including food 25-hydroxyvitamin D in intake estimates may reduce the discrepancy between dietary and serum measures of vitamin D status. J Nutri. 144:654–659. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Cashman KD, Seamans KM, Lucey AJ, Stöcklin E, Weber P, Kiely M and Hill TR: Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. J Clin Nutri. 95:1350–1356. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Leahy LG: Vitamin B Supplementation: What's the right choice for your patients? J Psychosoc Nurs Ment Health Serv. 55:7–11. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Miller AL: The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 13:216–226. 2008.PubMed/NCBI
|
|
56
|
Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW and Reynolds EH: Homocysteine, Folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 69:228–232. 2000.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Cuskelly GJ, McNulty H and Scott JM: Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet. 347:657–659. 1996.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Cardoso CC, Lobato KR, Binfaré RW, Ferreira PK, Rosa AO, Santos AR and Rodrigues AL: Evidence for the involvement of the monoaminergic system in the Antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry. 33:235–242. 2009.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Fernstrom JD: Aromatic amino acids and monoamine synthesis in the central nervous system: Influence of the diet. J Nutr Biochem. 1:508–517. 1990.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Fernstrom JD: Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev. 63:484–546. 1983.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kaufman S: Tyrosine Hydroxylase. In: John Wiley and Sons, 2: 251. pp103-220, 1995.
|
|
62
|
Nagatsu T, Levitt M and Udenfriend S: Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem. 239:2910–2917. 1964.PubMed/NCBI
|
|
63
|
Spector S, Gordon R, Sjoerdsma A and Udenfriend S: End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. Mol Pharmacol. 3:549–555. 1967.PubMed/NCBI
|
|
64
|
Neff NH, Ngai SH, Wang CT and Costa E: Calculation of the rate of catecholamine synthesis from the rate of conversion of tyrosine-14C to catecholamines. Effect of adrenal demedullation on synthesis rates. Mol Pharmacol. 5:90–99. 1969.PubMed/NCBI
|
|
65
|
Iuvone PM, Rauch AL, Marshburn PB, Glass DB and Neff NH: Activation of retinal tyrosine hydroxylase in vitro by cyclic AMP-dependent protein kinase: Characterization and comparison to activation in vivo by photic stimulation. J Neurochem. 39:1632–1640. 1982.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Carlsson A and Lindqvist M: Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 303:157–164. 1978.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Scally MC, Ulus I and Wurtman RJ: Brain tyrosine level controls striatal dopamine synthesis in haloperidol-treated rats. J Neural Transm. 41:1–6. 1977.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Iuvone PM, Galli CL, Garrison-Gund CK and Neff NH: Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons. Science. 202:901–902. 1978.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Fernstrom MH, Volk EA, Fernstrom JD and Iuvone PM: Effect of tyrosine administration on dopa accumulation in light- and dark-adapted retinas from normal and diabetic rats. Life Sci. 39:2049–2057. 1986.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Wurtman RJ, Larin F, Mostafapour S and Fernstrom JD: Brain catechol synthesis: Control by train tyrosine concentration. Science. 185:183–184. 1974.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Carlsson A, Davis JN, Kehr W, Lindqvist M and Atack CV: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol. 275:153–168. 1972.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Colzato LS, de Haan AM and Hommel B: Food for creativity: Tyrosine promotes deep thinking. Psychol Res. 79:709–714. 2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Abuhamdah S, Abuhamdah R, Howes MJ, Al-Olimat S, Ennaceur A and Chazot PL: Pharmacological and neuroprotective profile of an essential oil derived from leaves of Aloysia citrodora Palau. J Pharm Pharmacal. 67:1306–1315. 2015.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Ryu IS, Kim OH, Kim JS, Sohn S, Choe ES, Lim RN, Kim TW, Seo JW and Jang EY: Effects of β-Phenylethylamine on psychomotor, rewarding, and reinforcing behaviors and affective state: The role of dopamine D1 receptors. Int J Mol Sci. 22(9485)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Dourish CT: An observational analysis of the behavioural effects of beta-phenylethylamine in isolated and grouped mice. Prog Neuropsychopharmacol Biol Psychiatry. 6:143–1458. 1982.PubMed/NCBI View Article : Google Scholar
|
|
76
|
MacDonald A, van Wegberg AMJ, Ahring K, Beblo S, Bélanger-Quintana A, Burlina A, Campistol J, Coşkun T, Feillet F, Giżewska M, et al: PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 15(171)2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
van Wegberg AMJ, MacDonald A, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Giżewska M, et al: The complete European guidelines on phenylketonuria: Diagnosis and treatment. Orphanet J Rare Dis. 12(162)2017.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Molinoff PB and Axelrod J: Biochemistry of catecholamines. Annu Rev Biochem. 40:465–500. 1971.
|
|
79
|
Weiner N: Tyrosine-3-monooxygenase (tyrosine hydroxylase) In: Aromatic amino acid hydroxylases and mental disease. John Wiley & Sons, Ltd, New York, pp141-190, 1979.
|
|
80
|
Tripp G and Wickens JR: Neurobiology of ADHD. Neuropharmacology. 57:579–589. 2009.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Arnsten AF: Catecholamine regulation of the prefrontal cortex. J Psychopharmacol. 11:151–162. 1997.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Anisman H and Zacharko RM: Behavioral and neurochemical consequences associated with stressors. Ann N Y Acad Sci. 467:205–225. 1986.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Brooks DJ and Piccini P: Imaging in Parkinson's disease: The role of monoamines in behavior. Biol Psychiatry. 59:908–918. 2006.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Weiner N: Regulation of norepinephrine biosynthesis. Annu Rev Pharmacol. 10:273–290. 1970.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Cousins DA, Butts K and Young AH: The role of dopamine in bipolar disorder. Bipolar Disord. 11:787–806. 2009.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Koob GF and Volkow ND: Neurocircuitry of addiction. Neuropsychopharmacology. 35:217–238. 2010.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Døskeland AP and Flatmark T: Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. Eur J Biochem. 269:1561–1569. 2002.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Harris WS: Coates PM BJBMR. Omega-3 fatty acids. In: Encyclopedia of Dietary Supplements. 2nd edition. Vol 86. London and New York, Informa Healthcare, 2010.
|
|
89
|
Shin SS and Dixon CE: Oral fish oil restores striatal dopamine release after traumatic brain injury. Neurosci Lett. 496:168–171. 2011.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Rimm EB, Appel LJ, Chiuve SE, Djoussé L, Engler MB, Kris-Etherton PM, Mozaffarian D, Siscovick DS and Lichtenstein AH: American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health et al. Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation. 138:e35–e47. 2018.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Oken E, Kleinman KP, Berland WE, Simon SR, Rich-Edwards JW and Gillman MW: Decline in fish consumption among pregnant women after a national mercury advisory. Obstet Gynecol. 102:346–351. 2003.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Leaf A: Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. J Cardiovasc Med (Hagerstown). 8 (Suppl 1):S27–S29. 2007.PubMed/NCBI View Article : Google Scholar
|
|
93
|
JH Jones P and Papamandjaris AA: Lipids: Cellular Metabolism. In: Present Knowledge in Nutrition. 10th edition. Wiley, pp132-148, 2012.
|
|
94
|
Miller MR, Nichols PD and Carter CG: n-3 Oil sources for use in aquaculture-alternatives to the unsustainable harvest of wild fish. Nutr Res Rev. 21:85–96. 2008.PubMed/NCBI View Article : Google Scholar
|
|
95
|
U.S. Food, Drug Administration. Questions & answers for consumers concerning infant formulas, 2015.
|
|
96
|
Mitchell DC, Knight CA, Hockenberry J, Teplansky R and Hartman TJ: Beverage caffeine intakes in the U.S. Food Chem Toxicol. 63:136–142. 2014.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Logan J, Benveniste H, Kim R, Thanos PK and Ferré S: Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J Neurosci. 32:6711–6717. 2012.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E and Edgar DM: Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 21:1787–1794. 2001.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A and Franceschi D: Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 21(RC121)2001.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Abi-Dargham A, Kegeles LS, Martinez D, Innis RB and Laruelle M: Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: Results from a large cohort. Eur Neuropsychopharmacol. 13:459–468. 2003.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, et al: Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA. 301:1148–1154. 2009.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Nguyen TL, Tian YH, You IJ, Lee SY and Jang CG: Modafinil-induced conditioned place preference via dopaminergic system in mice. Synapse. 65:733–741. 2011.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R and Pappas NR: Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D (2) receptors. J Pharmacol Exp Ther. 291:409–415. 1999.PubMed/NCBI
|
|
104
|
Wuo-Silva R, Fukushiro DF, Borçoi AR, Fernandes HA, Procópio-Souza R, Hollais AW, Santos R, Ribeiro LT, Corrêa JM, Talhati F, et al: Addictive potential of modafinil and cross-sensitization with cocaine: A pre-clinical study. Addict Biol. 16:565–579. 2011.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N Jr and Schwarzschild MA: Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci. 21(RC143)2001.PubMed/NCBI View Article : Google Scholar
|
|
106
|
El Yacoubi M, Ledent C, Ménard JF, Parmentier M, Costentin J and Vaugeois JM: The stimulant effects of caffeine on locomotor behavior in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol. 129:1465–1473. 2000.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB, Urade Y and Hayaishi O: Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci. 8:858–859. 2005.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE, Winsky-Sommerer R, Semba K, Fredholm BB, Boison D, et al: Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci. 31:10067–10075. 2011.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P and Goldberg SR: Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci. 22:6321–6324. 2002.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Zheng X, Takatsu S, Wang H and Hasegawa H: Acute intraperitoneal injection of caffeine improves endurance exercise performance in association with increasing brain dopamine release during exercise. Pharmacol Biochem Behav. 122:136–143. 2014.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Volkow ND, Wang GJ, Logan J, Alexoff D, Fowler JS, Thanos PK, Wong C, Casado V, Ferre S and Tomasi D: Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Transl Psychiatry. 5(e549)2015.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Heimbach JT, Marone PA, Hunter JM, Nemzer BV, Stanley SM and Kennepohl E: Safety studies on products from whole coffee fruit. Food Chem Toxicol. 48:2517–2525. 2010.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y and Agrawal AK: Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol Dis. 22:421–434. 2006.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Alramadhan E, Hanna MS, Hanna MS, Goldstein TG, Avila SM and Weeks BS: Dietary and botanical anxiolytics. Med Sci Monit. 18:RA40–RA48. 2012.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Yokogoshi H, Kobayashi M, Mochizuki M and Terashima T: Effect of theanine, r-glutamyl ethyl amide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 23:667–673. 1998.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Yao J, Shen XN, Shen H and Wu M: Effects of theanine on monoamine neurotransmitters and related genes in cerebral ischemia-reperfusion injury rats. Zhonghua Yu Fang Yi Xue Za Zhi. 46:635–639. 2012.PubMed/NCBI(In Chinese).
|
|
117
|
Lee Y, Moon SJ and Montell C: Multiple gustatory receptors required for the caffeine response in Drosophila. Proc Natl Acad Sci USA. 106:4495–500. 2009.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Wright GA, Baker DD, Palmer MJ, Stabler D, Mustard JA, Power EF, Borland AM and Stevenson PC: Caffeine in floral nectar enhances a pollinator's memory of reward. Science. 339:1202–1204. 2013.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Fredholm BB, Bättig K, Holmén J, Nehlig A and Zvartau EE: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 51:83–133. 1999.PubMed/NCBI
|
|
120
|
Barone JJ and Roberts HR: Caffeine consumption. Food Chem Toxicol. 34:119–129. 1996.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Mitchell DC, Hockenberry J, Teplansky R and Hartman TJ: Assessing dietary exposure to caffeine from beverages in the U.S. population using brand-specific versus category-specific caffeine values. Food Chem Toxicol. 80:247–252. 2015.PubMed/NCBI View Article : Google Scholar
|
